Orchestra
PrivateLast Round
Debt
Apr 1, 2026
Total Funding Raised
$20M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Orchestra is a business/productivity software company that has developed a life sciences R&D management platform designed to optimize the planning, execution, and monitoring of complex drug development programs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orchestra Comparables
Compare Orchestra with similar companies based on industry and business-model similarity.
Orchestra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 1, 2026 | ||||
| Seed | Aug 4, 2025 |
Key People
Founding team and executive leadership
Orchestra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Seed |
| Haystack | Seed |
| Definition Capital | Seed |
| 8VC | Seed |
| Medtronic | Debt |
| Insight Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Grew 18% QoQ, from 17 to 20 employees.
- Apr 1, 2026
$20M debt round completed.
Orchestra Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Orchestra's valuation, stock price, and market status.
Is Orchestra a public or private company?
Orchestra is a private company.
What is the current stock price of Orchestra?
Orchestra is a private company with no public stock price. No recent secondary market data is available.
How much is Orchestra worth (valuation)?
Valuation information for Orchestra is not publicly available.
Can I buy Orchestra stock?
Orchestra shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Orchestra's last funding round?
Orchestra's most recent funding round was Debt on April 1, 2026.
Who are the main investors in Orchestra?
Key investors in Orchestra include Andreessen Horowitz, Haystack, Definition Capital, 8VC, Medtronic.
Will Orchestra IPO soon?
No public IPO plans have been announced for Orchestra.
How can I track Orchestra secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Orchestra's secondary market activity and sign up for updates.